COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

Director's Messages

Winter 2022

Happy New Year! Over the next few months, UCSD Health will launch new clinical research features in its Epic electronic health record (EHR) system. This will begin the shift from the eVelos clinical trial management system to UCSD’s Epic EHR. ACTRI’s Biomedical Informatics team, Moores Cancer Center (MCC), and UCSD Health Information Systems began partnering on the transition last year. Over 150 faculty and staff are contributing to the project through six user-centered workgroups. 

Fall 2021

As summer ends, ACTRI’s clinic and research pharmacy are supporting trials and other clinical research projects at pre-pandemic levels. We continue to add to our team of project managers to cover the expanding ACTRI services and facilities. Today’s message will focus on an accomplishment that highlights the importance of community engagement. UCSD was recently awarded $3 million from the state of California to address adverse childhood experiences (ACEs), such as neglect or growing up in a household with substance abuse, mental health problems, and even food insecurity.  More

Summer 2021

Despite the delay since our last ACTRI newsletter (October 2020), we have been very busy! From COVID vaccine studies to new medical informatics resources, to new Centers (Dissemination and Implementation Science Center and Translational Immunogenomics) to our new Med-Gap program for medical student researchers, the last year has been action-packed. My sincere thanks to everyone who worked to keep our clinic, services, and other facilities running. Today’s message will focus on our new Device Acceleration Center (DAC) to give an idea about how ACTRI resources are being used to expand opportunities for collaboration. The goal of the DAC is to ensure that commercialization resources at UC San Diego can be leveraged by our UC San Diego innovators on campus. More

Fall 2020

As we continue to face the challenging landscape of the coronavirus pandemic, we would like to thank our amazing clinic staff who remain focused and dedicated. They are working tirelessly to ensure patients are enrolled in new vaccine trials and continue to receive the care needed for other enrolled studies. The staff also actively engage new researchers who seek to bring additional clinical trials to our study teams. More

Summer 2020

I am delighted to announce that the Altman Clinical and Translational Research Institute (ACTRI) has received a renewal of our five-year Clinical and Translational Science Award (CTSA) totaling approximately $55 million from the National Center for Advancing Translational Science (NCATS), and brings our total support since the inception of the ACTRI to approximately $144 million.  More

Spring 2020

The COVID-19 pandemic continues to disrupt lives and bring unwelcome news and ever-changing guidelines. We at the ACTRI continue to work hard to ensure that our research participants, clinical researchers, study teams and staff have access to critical resources and remain up to date on the latest developments. The circumstances have led to creative and sometimes challenging new developments, including moving our staff to a mostly virtual capacity, facilitating the upgrade to our pharmacy, releasing a new virtual education game, IRB Please, for investigators and new approaches to keeping our clinic operational for interventional clinical trials. more

Winter 2020

Another year has begun at the CTRI, with many exciting updates. We have been busy making great strides in several areas. Our Phase I Clinical Trial Unit has now performed 40 trials since it opened just 2 years ago, including neuroscience, endocrinology, rheumatology, cardiology, anesthesiology and cancer trials and providing 24-hour MD coverage when needed. Additionally, our dedicated pharmacy has provided outstanding service managing drugs for 142 studies this past year. The Center for Clinical Research continues to grow rapidly, increasing from 2,500 visits in its first year to more than 8,000 visits this year, with more than 250 active protocols. more

Summer 2018

I am pleased to announce the availability of the ACTRI Virtual Research Desktop (VRD) for UC San Diego Health research scientists and staff. The service is a collaboration between ACTRI and UC San Diego Health System Information Services (IS). The VRD is a HIPAA-compliant virtual desktop that operates in a secure private cloud server environment managed by the ACTRI and housed in a UC San Diego data center. more

Spring 2018

I am pleased to announce that Tricorder medical device testing will continue at UC San Diego Altman Clinical and Translational Research Institute (ACTRI). Through a new initiative – the Tricorder Device Development Project – ACTRI and the Jacobs School of Engineering are creating a sustainable testing center for novel consumer and medical devices that can improve health. more

Winter 2017-2018

We established the Center for Life Course Research at UC San Diego Altman Clinical and Translational Research Institute (ACTRI) in 2015, creating a home for ACTRI researchers studying health issues that span multiple life stages. Broadly, life course research investigates the long term effects of social, behavioral and biologic determinants of disease across the life span or across generations. The goal of the Center is to develop and support multi-disciplinary approaches that bring pediatricians, neonatologists, internists, family medicine physicians and geriatrics specialists together to study special populations and life course transitions. more

Fall 2017

It began as an experiment four years ago. UC San Diego Altman Clinical and Translational Research Institute (ACTRI) and UC San Diego Institute of Engineering in Medicine (IEM) launched an initiative to bring physicians and engineers together to develop and implement novel engineering solutions for specific unmet medical needs. Since establishing the Galvanizing Engineering in Medicine (GEM) program, we have awarded 15 physician-engineer teams with diverse and innovative projects. Successful examples include a home system to predict cystic fibrosis flares; injectable biomaterial for treating pelvic floor disorders; 3-D printable, disposable endoscopes; and epidermal electronics technology for minimally invasive monitoring of brain function in newborns. more

Summer 2017

I am delighted to announce four new leaders at UC San Diego Altman Clinical and Translational Research Institute (ACTRI). They offer special expertise and fresh insight in the areas of biomedical informatics, computational biology, clinical trials, and mentoring of the next generation of translational scientists. By continuously adding and refreshing the outstanding talent that works at the ACTRI, we aim to facilitate research, support our less experienced investigators, and provide new tools at UC San Diego for our investigators. more

Spring 2017

I am pleased to announce our participation in two new NIH initiatives that create nationwide networks to support critical facets of clinical trials: The Trial Innovation Network (TIN) and the Accrual to Clinical Trials program (ACT). UC San Diego Altman Clinical and Translational Research Institute (ACTRI) serves as the local link to these exciting new efforts. The goal of the TIN is to provide consultation and services for the design and initiation of new multi-center clinical trials, while ACT provides new tools for assessing study feasibility. more

Winter 2016-2017

Obtaining preliminary data is essential to the success of early-stage clinical studies, and is the cornerstone for receiving federal or foundation support for larger scale studies. Last year, the Altman Clinical and Translational Research Institute (ACTRI) implemented a Vouchers Program to enable researchers to gather preliminary results for grant submissions. more

Summer 2016

I’m very pleased to announce the opening of our expanded Center for Clinical Research (CCR) at our new home, the Altman Clinical and Translational Research Institute (CTRI). This fully staffed clinic includes 18,000 square feet of the first floor and supports a wide range of translational research studies. The CCR opened following a brief gap in operations during the move. The clinic staff did an outstanding job preparing the clinic space for clinical trials and participants. Since opening its doors in June, 276 participants have used the space. more

Spring 2016

I am delighted to announce we will begin moving into our new home, the Altman Clinical and Translational Research Institute (ACTRI) building, this spring. We are preparing for this phased move as the finishing touches are being added to the ACTRI. On March 4, under sunny skies, we dedicated the building during a ribbon cutting celebration. more

Winter 2016

I am pleased to announce expanded programs in our Education unit at the UC San Diego CTRI. Our new NIH grant, awarded in August, enables us to develop additional education and training opportunities for a growing workforce. I’m especially pleased about the growth of our successful KL2 program, the addition of the TL1 postdoctoral program, and our launch of new courses and seminars. more


Past Director's Messages

2012 - 2015